Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00412_DB00930_nanopub.RAR_GQvHFApcxjgpCxFNA6lYadPZGlPLabD8F_oXEFG90#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00412_DB00930 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00412_DB00930 label "DDI between Rosiglitazone and Colesevelam - Bile Acid Sequestrants may decrease the absorption of Antidiabetic Agents (Thiazolidinedione). Separate the dosing of bile acid sequestrants and thiazolidinediones by at least 2 hours. Monitor for reduced effects of the antidiabetic agents. [drugbank_resource:DB00412_DB00930]" assertion.
- drugbank_resource:DB00412_DB00930 identifier "drugbank_resource:DB00412_DB00930" assertion.
- drugbank_resource:DB00412_DB00930 title "DDI between Rosiglitazone and Colesevelam - Bile Acid Sequestrants may decrease the absorption of Antidiabetic Agents (Thiazolidinedione). Separate the dosing of bile acid sequestrants and thiazolidinediones by at least 2 hours. Monitor for reduced effects of the antidiabetic agents." assertion.
- drugbank:DB00930 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00412_DB00930 assertion.
- drugbank:DB00412 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00412_DB00930 assertion.